Drug Companies Will Be Fined
Health and Human Services’ Resources and Services Administration released a final rule that imposes fines on drug companies that overcharge
Read More
Part D/Prescription Drugs
Where Does Alzheimer’s Treatment Go From Here?
(By Bret Stetka for NPR) In a disappointment to Alzheimer’s patients and researchers, drugmaker Eli Lilly said in late November
Read MoreMedicare: Important but Flawed
The Medicare program provides an important layer of protection for individuals who qualify but the program is confusing to majority
Read MoreGermany’s Model For Drug Price Regulation Could Work In The US
(By Karl Lauterbach, John McDonough and Elizabeth Seeley for Health Affairs Blog, posted December 29, 2016) Donald Trump and Hillary
Read MoreNew Drugs Approvals Slowed Down in 2016
The Food and Drug Administration cleared only twenty-two new medicines for sale in 2016 compared to forty-five in 2015. Read
Read MoreMedicare’s 2017 Changes
There are several areas of Medicare change that beneficiaries need to be aware of, and Matthew Frankel has outlined them
Read MoreDisenrollment Period
Did you miss your chance to drop your Medicare Advantage Plan (Medicare Part C) and return to original Medicare during
Read MoreCAR-T therapy makes early inroads in treating brain cancer
(By Meghana Keshavan for STAT) Glioblastoma is one of the deadliest cancers — an illness that responds to few treatment options,
Read MoreSTAT’s stats of the year: 2016 by the numbers
(By STAT Staff) 1.3 million The number of times ads were aired on national television this year promoting prescription and over-the-counter drugs and
Read MoreH.P. Acthar
Per Medicare data, H.P. Acthar, a drug produced by Mallinckrodt PLC, was the single most expensive drug per patient paid
Read More